GlassScriptPhysician profile
David A Dorsey
NPI 1891992608
$979.07
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $78.33 · 2021: $296 · 2022: $138 · 2023: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $278.35 | 2019-2021 | |
| Lilly USA, LLC | $257.58 | 2021-2023 | Mounjaro |
| Pfizer INC. | $124.81 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.83 | 2019 | |
| Shire North American Group INC | $46.05 | 2019 | |
| Sanofi Pasteur INC. | $32.21 | 2019-2020 | |
| Amarin Pharma, INC. | $32.20 | 2019-2020 | |
| Glaxosmithkline, LLC. | $24.35 | 2019 | |
| Abbvie INC. | $17.43 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.77 | 2019 | |
| Eisai INC. | $15.10 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.54 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.92 | 2020 | |
| Genentech USA, INC. | $12.68 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dorsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.